Kevin Lynch
- Co-authors
- Ming PeiCraig L. SlingluffMax O. MeneveauTyler PizzuteIleana S. MauldinSamuel YoungNolan A. WagesVíctor H. Engelhard
- Topics
- Immunotherapy and Immune Responses (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)vaccines and immunoinformatics approaches (4 papers)
- Cited by
- GeneticsImmunologyOncology
- Partner nations
- United StatesChinaSweden
In The Last Decade
Kevin Lynch
29 papers receiving 353 citations
Peers
Comparison fields: 5 of 67
- Oncology 134
- Immunology 131
- Molecular Biology 75
- Surgery 71
- Genetics 70
Countries citing papers authored by Kevin Lynch
This map shows the geographic impact of Kevin Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Lynch more than expected).
Fields of papers citing papers by Kevin Lynch
This network shows the impact of papers produced by Kevin Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Lynch. The network helps show where Kevin Lynch may publish in the future.
Co-authorship network of co-authors of Kevin Lynch
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Lynch. A scholar is included among the top collaborators of Kevin Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Lynch. Kevin Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 14 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 14 | |
| 10 | 1 | |
| 11 | 10 | |
| 12 | 75 | |
| 13 | 4 | |
| 14 | 2 | |
| 15 | 7 | |
| 16 | 23 | |
| 17 | 26 | |
| 18 | 63 | |
| 19 | 56 | |
| 20 | No evidence for an adverse interaction between zoledronic acid and thalidomide Preliminary safety analysis from the Australasian leukaemia and lymphoma group MM6 Myeloma Trial | 2 |
About Kevin Lynch
Kevin Lynch is a scholar working on Oncology, Immunology and Biological Psychiatry, having authored 29 papers that have together received 355 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and vaccines and immunoinformatics approaches (4 papers). The work is most often cited by research in Genetics (70 citations), Immunology (131 citations) and Oncology (134 citations). Kevin Lynch has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Ming Pei, Craig L. Slingluff, Max O. Meneveau, Tyler Pizzute, Ileana S. Mauldin, Samuel Young, Nolan A. Wages, Víctor H. Engelhard, Taryn E. Hassinger and Pankaj Kumar. Their work appears in journals such as Blood, The Journal of Immunology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.